# ClinicalTrials.gov record NCT03070886

> PeptideScanner retained ClinicalTrials.gov record NCT03070886 at 2026-07-30T16:19:03.056Z. Its registry update date was 2026-06-25, and PeptideScanner's reviewed identity mapping was leuprolide.

- Evidence object: `story:clinicaltrials-gov-nct03070886-leuprolide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-06-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-08
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct03070886-leuprolide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03070886-leuprolide-v1.json
- Content SHA-256: `81b167e4beb611b9bc600b4db03925d26fd060b440315032b904206297876d82`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT03070886 ([`ctg-observation-nct03070886-2026-06-25-73b6ee0c06fe`](#source-ctg-observation-nct03070886-2026-06-25-73b6ee0c06fe))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT03070886 at 2026-07-30T16:19:03.056Z. Its registry update date was 2026-06-25, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct03070886-2026-06-25-73b6ee0c06fe`](#source-ctg-observation-nct03070886-2026-06-25-73b6ee0c06fe))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT03070886 at 2026-07-30T16:19:03.056Z. Its registry update date was 2026-06-25, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct03070886-2026-06-25-73b6ee0c06fe`](#source-ctg-observation-nct03070886-2026-06-25-73b6ee0c06fe))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct03070886-2026-06-25-73b6ee0c06fe`](#source-ctg-observation-nct03070886-2026-06-25-73b6ee0c06fe))

## Sources

<a id="source-ctg-observation-nct03070886-2026-06-25-73b6ee0c06fe"></a>
- **ClinicalTrials.gov record NCT03070886 · retained source version 2026-06-25:73b6ee0c06fe3c9dff9b8bff292852e7ab3dab85f61971d6960883d037021a86** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT03070886) (`ctg-observation-nct03070886-2026-06-25-73b6ee0c06fe`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT03070886." Version 1, published 2026-08-08. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03070886-leuprolide-v1.json SHA-256: 81b167e4beb611b9bc600b4db03925d26fd060b440315032b904206297876d82.